BRANDICOURT OLIVIER — SEC Form 4 filings
SEC reporting owner CIK 1508518. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-16.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-03-04 to 2026-06-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vaxcyte, Inc. (PCVX) | Director | 4 | — | — | 7 |
| BeOne Medicines Ltd. (ONC) | Director | 4 | — | — | 6 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Director | 3 | — | — | 5 |
Form 4 filings — BRANDICOURT OLIVIER
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-16 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 2,194 @ $0 · Grant/award (A): 11,034 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | BeOne Medicines Ltd. (ONC) | Grant/award (A): 18,980 @ $0 | EDGAR |
| 2026-05-22 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/award (A): 671 @ $0 · Grant/award (A): 1,441 (derivative) @ $0 | EDGAR |
| 2026-01-16 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 1,357 @ $0 · Grant/award (A): 6,750 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 1,148 @ $0 · Grant/award (A): 5,807 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | BeiGene, Ltd. (BGNE) | Grant/award (A): 10,985 @ $0 · Grant/award (A): 22,750 (derivative) @ $0 | EDGAR |
| 2025-05-12 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/award (A): 775 @ $0 · Grant/award (A): 1,558 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 40,113 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | BeiGene, Ltd. (BGNE) | Grant/award (A): 16,341 @ $0 · Grant/award (A): 34,151 (derivative) @ $0 | EDGAR |
| 2024-05-20 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/award (A): 5,228 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | BeiGene, Ltd. (BGNE) | Grant/award (A): 27,794 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1508518 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →